Consumer drug costs should be FTC focus

DLC Board Chair Stewart Perry shared a prepared statement at a February 17, 2022, meeting of the Federal Trade Commission (FTC). DLC urged the FTC to include consumer cost in its proposed study of pharmacy benefit manager (PBM) practices impacting community pharmacies and prescription drug prices.